Kahn Swick & Foti, LLC (KSF) is reminding investors of Hims & Hers Health, Inc. (NYSE: HIMS) with losses over $100,000 that they have until November 2, 2026, to file lead plaintiff applications in a securities class action lawsuit. The lawsuit alleges that Hims & Hers Health and its executives failed to disclose material information regarding the sharing of sensitive health data and deceptive billing practices, which led to a significant drop in stock price after an FTC announcement on July 29, 2026. KSF is encouraging affected investors to contact them to discuss their legal rights and potential recovery.
Original sourceHIMSNYSEConsumer Defensive
HIMS & HERS HEALTH INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$26.00
+8.06%
Alpha Vantage · 11/6/2026
Industry: Household & Personal ProductsCategory: Domestic Common Stock Primary ClassCurrency: USDNews: 1 recent
Analyze HIMS free One-year price history
Adjusted daily closes · 252 observations · as of Nov 6, 2026
1 month
-7.3%
3 months
-18.2%
6 months
-8.0%
1 year
-37.4%
Year to date
-19.9%
52-week range
$14.52 – $41.52
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$6.07B
P/E
-42.7
P/B
18.7
P/S
2.4
Revenue
$2.58B
Net income
-$142.03M
Diluted EPS
-0.63
Gross margin
68.40%
Net margin
-5.50%
Return on equity
-30.00%
Total debt
$1.55B
Cash
$609.81M
Free cash flow
$61.63M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | $753.21M | -$86.29M | 63.80% | -11.50% | -$68.19M |
| Mar 31, 2026 | $608.1M | -$92.12M | 65.20% | -15.10% | $53.03M |
| Dec 31, 2025 | $617.82M | $20.6M | 71.90% | 3.30% | -$2.57M |
| Sep 30, 2025 | $598.98M | $15.77M | 73.80% | 2.60% | $79.36M |
| Jun 30, 2025 | $544.83M | $42.51M | 76.40% | 7.80% | -$69.43M |
| Mar 31, 2025 | $586.01M | $49.49M | 73.50% | 8.40% | $50.05M |
| Dec 31, 2024 | $481.14M | $26.03M | 76.80% | 5.40% | $59.5M |
| Sep 30, 2024 | $401.56M | $75.59M | 79.20% | 18.80% | $79.39M |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent HIMS news
All market newsBusiness Wire·79 signal
Hims & Hers Health 72 Hour Deadline Alert: Kahn Swick & Foti, LLC Reminds Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuit Against Hims & Hers Health, Inc. - HIMS